Holen Sie sich die Stockscreener-App
6.50
2.99%
-0.20
Handel nachbörslich:
6.53
0.03
+0.46%
Schlusskurs vom Vortag:
$6.70
Offen:
$6.81
24-Stunden-Volumen:
28,035
Relative Volume:
0.53
Marktkapitalisierung:
$65.36M
Einnahmen:
$75.67M
Nettoeinkommen (Verlust:
$-31.15M
KGV:
-23.41
EPS:
-0.2777
Netto-Cashflow:
$-39.79M
1W Leistung:
+10.46%
1M Leistung:
-19.75%
6M Leistung:
-58.73%
1J Leistung:
-63.89%
1-Tages-Spanne:
$6.41
$6.81
1-Wochen-Bereich:
$5.6145
$6.97
52-Wochen-Spanne:
$4.815
$31.50
Optinose Inc Stock (OPTN) Company Profile
Firmenname
Optinose Inc
Sektor
Telefon
267-364-3500
Adresse
777 TOWNSHIP LINE ROAD, YARDLEY, PA
Vergleichen Sie OPTN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
OPTN
Optinose Inc
|
6.50 | 65.36M | 75.67M | -31.15M | -39.79M | -0.2777 |
|
ZTS
Zoetis Inc
|
163.31 | 73.68B | 9.15B | 2.43B | 2.31B | 5.32 |
|
HLN
Haleon Plc Adr
|
9.46 | 42.77B | 14.26B | 1.55B | 0 | 0.3383 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.26 | 42.04B | 30.27B | 1.93B | 3.45B | 0.6044 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
21.24 | 24.07B | 16.77B | -959.00M | 1.37B | -0.85 |
|
VTRS
Viatris Inc
|
12.28 | 14.66B | 15.05B | -883.30M | 1.89B | -0.74 |
Optinose Inc Stock (OPTN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-03-11 | Eingeleitet | H.C. Wainwright | Buy |
| 2023-08-21 | Eingeleitet | Lake Street | Buy |
| 2022-10-21 | Fortgesetzt | Jefferies | Buy |
| 2021-04-07 | Fortgesetzt | RBC Capital Mkts | Outperform |
| 2019-12-18 | Eingeleitet | Cowen | Outperform |
| 2018-08-08 | Eingeleitet | Cantor Fitzgerald | Overweight |
Alle ansehen
Optinose Inc Aktie (OPTN) Neueste Nachrichten
HC Wainwright Issues Positive Forecast for OptiNose (NASDAQ:OPTN) Stock Price - Defense World
Optinose stock price target raised at H.C. Wainwright given reverse split - Investing.com Canada
OptiNose (NASDAQ:OPTN) Shares Down 6.1%Time to Sell? - MarketBeat
OptiNose: Q1 Earnings Snapshot - Marketscreener.com
Optinose Announces Board Changes - Marketscreener.com
OptiNose stock hits 52-week high of $6.2 amid market fluctuations - Investing.com Nigeria
Midday Market Movers: Biggest Stock Declines of the Day – Stock Market - HPBL
OptiNose stock hits 52-week high of $6.2 amid market fluctuations By Investing.com - Investing.com South Africa
Stock market news: Coeptis Therapeutics Holdings -96.03%, OptiNose -93.07% among biggest losers during mid day trading - Business Upturn
OptiNose (NASDAQ:OPTN) Sees Unusually-High Trading VolumeWhat's Next? - MarketBeat
Stock market today: Coeptis Therapeutics Holdings -95.79%, OptiNose -93.64% among biggest losers in early trading - Business Upturn
Optinose Announces 1-for-15 Reverse Stock Split - MSN
Optinose to effect 1-for-15 reverse stock split for Nasdaq compliance - MSN
OptiNose, Inc. (NASDAQ:OPTN) Sees Large Decline in Short Interest - MarketBeat
Yardley-Based Optinose Implements Reverse Stock Split to Boost Share Price, Avoid NASDAQ Delisting - BUCKSCO.Today
OptiNose Stock Scheduled to Reverse Split on Tuesday, December 31st (NASDAQ:OPTN) - Defense World
Optinose to enact 1-for-15 reverse stock split under threat of Nasdaq delisting - The Business Journals
Optinose announces reverse stock split to meet Nasdaq rules - Investing.com
Optinose (OPTN) Announces 1-for-15 Reverse Stock Split to Maintain Nasdaq Listing Compliance - StockTitan
Optinose CEO Mahmoud Ramy A sells $2,030 in common stock By Investing.com - Investing.com South Africa
Optinose CEO Mahmoud Ramy A sells $2,030 in common stock - Investing.com India
Optinose chief legal officer sells shares worth $1,342 By Investing.com - Investing.com Australia
Optinose chief legal officer sells shares worth $1,342 - Investing.com
SEC Form DEF 14A filed by OptiNose Inc. - Quantisnow
Form DEF 14A OptiNose, Inc. For: Dec 12 - StreetInsider.com
Former CEO Launches Wayne-based Enginuity Rx, Integrated Provider of End-to-End Digital Care - MSN
Optinose to Present at Piper Sandler Healthcare Conference - MyChesCo
SEC Form PRE 14A filed by OptiNose Inc. - Quantisnow
Optinose to Present at Piper Sandler Healthcare Conference, Showcasing ENT Portfolio | OPTN Stock News - StockTitan
Optinose to Present at the Piper Sandler 36th Annual Healthcare Conference - GlobeNewswire
Former Optinose CEO Peter Miller comes out of retirement to launch new startup - The Business Journals
OptiNose, Inc. (NASDAQ:OPTN) Might Not Be As Mispriced As It Looks After Plunging 31% - Simply Wall St
91,084 Shares in OptiNose, Inc. (NASDAQ:OPTN) Acquired by GSA Capital Partners LLP - Defense World
Stonepine Capital Management, LLC Increases Stake in OptiNose Inc - GuruFocus.com
OptiNose (OPTN) Reports Break-Even Earnings for Q3 - MSN
OptiNose (STU:0OP) Owner Earnings per Share (TTM) : -0.31 (As of Sep. 2024) - GuruFocus.com
Optinose to Announce Q3 2024 Financial Results with Investor Call - MSN
OptiNose (STU:0OP) 5-Year EBITDA Growth Rate : 41.10% (As of Sep. 2024) - GuruFocus.com
OptiNose stock plunges to 52-week low at $0.37 amid market challenges - Investing.com
FY2024 EPS Estimates for OptiNose Increased by HC Wainwright - Defense World
Earnings Release: Here's Why Analysts Cut Their OptiNose, Inc. (NASDAQ:OPTN) Price Target To US$3.50 - Simply Wall St
OptiNose, Inc. (NASDAQ:OPTN) Just Reported, And Analysts Assigned A US$3.50 Price Target - Yahoo Finance
FY2024 EPS Estimates for OptiNose Raised by HC Wainwright - MarketBeat
Great Point Partners LLC Bolsters Position in OptiNose Inc - GuruFocus.com
HC Wainwright Reaffirms Buy Rating for OptiNose (NASDAQ:OPTN) - Defense World
OptiNose Third Quarter 2024 Earnings: EPS: US$0.002 (vs US$0.083 loss in 3Q 2023) - Yahoo Finance
Optinose stock target down as analyst cites challenges in Xhance sales guidance - Investing.com UK
Optinose Reports Q3 2024 Financial Results, Highlights XHANCE Performance - MyChesCo
Finanzdaten der Optinose Inc-Aktie (OPTN)
Umsatz
Nettogewinn
Free Cashflow
ENV
Optinose Inc-Aktie (OPTN) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Mahmoud Ramy A | Chief Executive Officer |
Dec 17 '24 |
Sale |
0.44 |
4,614 |
2,030 |
1,197,483 |
0.58%
2.71%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):